Feasibility and Safety of Physical Exercise in Men With Prostate Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-04-14

Study Completion Date

2022-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prostate cancer (PCa) is among the most widespread in the male population and represents 19% of all cancers diagnosed from the age of fifty, in Italy. Androgen deprivation therapy (ADT) and Radiotherapy (RT) are used for increase survival. However, both therapies are associated with significant side effects, such as fatigue, loss of muscle mass and strength, cognitive decline that together lead to an increase risk of accidental falls and fractures.

Guidelines for cancer survivors recommend Physical Exercise (PE) as a strategy to reduce several side effects of therapies. However, most people living with cancer do not meet current exercise recommendations.

Indeed, an effective PE program requires the application of long-term, moderate to high intensity activity. Thus it may be difficult to implement this type of recommendation in patient with PCa.

Therefore, this study aims to develop an experimental PE intervention testing their feasibility and safety and the patients' satisfaction, aimed at improving the health conditions of the patients with PCa receiving ADT and RT. Furthermore, long-term falls and fracture events will be monitored.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate Cancer

NCT03982095

Prostatic Neoplasm Physical Activity Health Behavior +1 more

COMPLETED

Physical Training and Cancer-a Multicenter Clinical Trial

NCT02473003

Breast Cancer Colorectal Cancer Prostate Cancer

ACTIVE_NOT_RECRUITING NA

Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer

NCT03672396

Castration-resistant Prostate Cancer Androgen Deprivation Therapy

COMPLETED NA

Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors

NCT00335491

Bladder Cancer Breast Cancer Colorectal Cancer +6 more

COMPLETED NA

The Effect of a Structured Strength and Endurance Training Program on Quality of Life, Fitness, Blood Parameters and Survival in Prostate Cancer Patients

NCT07126860

Prostate Cancer Metastatic Prostate Cancer Prostate Cancer (Post Prostatectomy) +2 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The non-randomized feasibility and pilot study aims to evaluate the feasibility and safety of a structured, multicomponent, supervised and unsupervised exercise program.

Secondary outcome will be evaluate the change in the health condition, in particular muscle strength, cognitive function, fatigue, balance, anxiety and depression level, and quality of life.

The PE program will be conducted at the "Virgilio Camparada" Municipal Athletic Track in the city of Reggio Emilia (IT). Patients will be participate in a supervised exercise program with three sessions per week, for eight weeks. Subsequently, the intervention will continue further for four weeks maintaining one supervised session and two unsupervised sessions a week. Finally, sessions will be performed without supervision for further eight weeks. The overall duration of the intervention will be twenty weeks. In addition, an evaluation will be performed at one year from baseline to monitor long-term fall and fracture events.

At baseline will be the following assessment:

\- clinical and anthropometric data and the Six Minute Walking Test (6MWT) to determine the intensity of aerobic exercise.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer Androgen Deprivation Therapy Radiotherapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Feasibility pilot study

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PE intervention

Aerobic, resistance, and neuromotor exercise

Group Type EXPERIMENTAL

PE Intervention

Intervention Type BEHAVIORAL

Each single exercise session will last for one hour and will consist of a combination of the following elements:

* Aerobic Exercise (AE): 20-30 minutes at moderate-high intensity, from 60 to 80% of the maximum heart rate (% HRmax).
* Resistance Exercise (RE): 30 minutes of strength activity of the major muscle groups.
* Neuromotor Exercise (NE): will be integrated with strength exercises and will consist of jumping, balance and coordination activities

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PE Intervention

Each single exercise session will last for one hour and will consist of a combination of the following elements:

* Aerobic Exercise (AE): 20-30 minutes at moderate-high intensity, from 60 to 80% of the maximum heart rate (% HRmax).
* Resistance Exercise (RE): 30 minutes of strength activity of the major muscle groups.
* Neuromotor Exercise (NE): will be integrated with strength exercises and will consist of jumping, balance and coordination activities

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Histologically documented diagnosis of PCa;
* Undergo ADT and RT during the study period;
* At least 18 years old;
* Willing and able to give written informed consent;
* Able to read and understand Italian Language;